Table 2.
Major cardiac stem cell research and preclinical studies
| Study procedure | Animal model | Cells | Major findings | Date | Ref. |
|---|---|---|---|---|---|
|
-isolation of c-kitPOS cells -immunocytochemistry analysis -induction of MI -implantation of myocytes cells |
rat | c-kitPOS cells | -improved of functional performance of the postinfarcted hearts injected with Lin(-) c-kitPOS cells | 2003 | [25] |
| -using transgenic mice to determine the location of c-kitPOS cells in a healthy heart and in the heart after myocardial infarction | mouse | c-kitPOS cells |
- the number of c-kitPOS cells is higher at birth compared to adults - an increased number of c-kitPOS cells was observed in the infarction region |
2008 | [32] |
|
-isolation of c-kitPOS cells with high GATA-4 expression -co-culture of c-kitPOS GATA-4 cells with adult cardiomyocytes |
rat | c-kitPOS cells | -c-kitPOS GATA-4 cells affect cardiomyocyte survival by inducing IGF1R | 2010 | [33] |
|
-isolation of CDCs -induction of MI -intramyocardial injection of CDCs |
pig | autologous CDCs |
-preservation of left ventricular function - minimization of adverse ventricular remodeling |
2011 | [35] |
|
-isolation of CDCs from rat and human hearts -induction of MI in rats -intramyocardially CDCc injection in groups: syngenic group, allogenic group, xenogeneic group |
rat |
allogenic CDCs syngenic CDCs |
-allogenic CDCs promotes cardiac regeneration -improvement in cardiac function was observed in rat models |
2012 | [36] |
|
-preparation of cardiospheres -injection cardiospheres in the peri-infarct zone |
rat | allogenic CDCs |
-reduced scar size -increased cardiac function |
2013 | [37] |
|
-induction of chronic infarction -intramyocardial injection of CSCs |
dog | autologous CSCs |
-less increase in left ventricular end-systolic volume -preservation of left ventricular ejection fraction |
2013 | [41] |
|
-induction of MI -intracoronary infusion of CDCs |
pig | allogenic CDCs |
-MRI is a useful tool for assessing dynamic changes in the infarct and monitoring regenerative efficacy -decreased scar size -increased myocardium viability |
2013 | [38] |
|
-isolation and culture of human MSCs and CSCs -induction of MI in pig -intramyocardial injection of MSCS and CSCs |
pig | Xenogeneic MSCs and CSCs |
-reduced scar size -restoration of diastolic and systolic function of the left ventricle |
2013 | [39] |
| -development of the c-kitPOS cells isolation protocol |
rat mouse |
c-kitPOS cells | -identification and isolation of c-kitPOS cells | 2014 | [31] |
|
-isolation of CSCs cells -intracoronary infusion of autologous CSCs |
pig | autologous CSCs |
-improves regional and global left ventricular function -promotes cardiac and vascular regeneration in pigs with old MI |
2014 | [40] |
|
-preparation of CDCs -randomized -induction of MI -intracoronary administration of CDCs |
pig | allogenic CDCs |
-reduction of infract size -CDCs are effective in cardioprotection -prevention of microvascular obstruction |
2015 | [26] |
|
-isolation of human CSCs -identification of c-kitPOS cells with PIM1 overexpression -intramyocardial injection of CSCs to Yorkshire swine |
pig | human CSCs |
-PIM1 overexpression enhanced the effect of intramyocardial delivery of CSCs to infarcted porcine hearts -reduced scar size |
2017 | [34] |
CDCs - cardiosphere-derived stem cells, CSCs - Cardiac Stem Cells, MI - Myocardial Infarction, MRI - Magnetic Resonance Imaging, MSCs - Mesenchymal Stem Cells